91 results
Page 3 of 5
8-K
EX-99.1
o0tekv5
12 Mar 20
Neoleukin Therapeutics Announces Year End Financial Results
4:02pm
8-K
EX-1.1
isarmfs7
19 Dec 19
Announces Pricing of $75.0 Million Public Offering
12:00am
424B5
bzbtsuptb 9m7ng66
18 Dec 19
Prospectus supplement for primary offering
5:38pm
424B5
fmrfez l8dkhdlp
17 Dec 19
Prospectus supplement for primary offering
4:43pm
8-K/A
EX-99.3
n707aatz6 d5w9xmbt
11 Oct 19
Index to Financial Statements
8:34am
8-K/A
EX-99.2
biw7ue
11 Oct 19
Index to Financial Statements
8:34am
8-K/A
EX-99.1
t65lfu2bbq 8lbjpc4km
11 Oct 19
Index to Financial Statements
8:34am
PRE 14A
n277tb whvpzr
20 Sep 19
Preliminary proxy
8:31am
8-K
EX-99.2
e18w4xu
12 Aug 19
Entry into a Material Definitive Agreement
8:01am
8-K
EX-10.3
3olgy96o
6 Aug 19
Entry into a Material Definitive Agreement
7:32am
8-K
gkbcuil
6 Aug 19
Entry into a Material Definitive Agreement
7:32am